Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: A case-control study

International Urology and Nephrology

Volumn 44, Issue 3, 2012, Pages 829-839

  Pradeep, A R ^a   Kathariya, Rahul ^a   Raju, P Arjun ^a   Rani, R Sushma ^b   Sharma, Anuj ^a   Raghavendra, N M ^a  

^a Research Institute   (India)

^b Nephrolife Care (India) Pvt Ltd   (India)

Author keywords

Chronic kidney diseases CKD stage V; GFR; Pentraxin 3; Periodontitis; Plasma

Indexed keywords

PENTRAXIN 3;

ADULT; ARTICLE; BIOTINYLATION; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIODONTAL DISEASE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; ROC CURVE; SERUM AMYLOID P-COMPONENT; YOUNG ADULT;

EID: 84864285004     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9997-7     Document Type: Article

References (56)

1. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
2. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(suppl 1):S1-S266
3. Centers for Disease Control and Prevention (2007) Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morbid Mortal Wkly Rep 56:161-165
4. Go AS, Chertow G, Fan D, McCulloch CE, Hsu Cy (2004) Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351: 1296-1305
5. Bang H, Vupputuri S, Shoham DA et al (2007) Screening for occult renal disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 167: 374-381 (Pubitemid 46333938)
6. Fisher MA, Taylor GW, Shelton BJ et al (2008) Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis 51:45-52 (Pubitemid 350296524)
7. Stevens LA, Coresh J, Green T, Levey AS (2006) Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354:2473-2483 (Pubitemid 43855050)
8. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J (2003) Risk factors for chronic kidney disease: a prospective study of 23, 534 men and women in Washington County, Maryland. J Am Soc Nephrol 14:2934-2941 (Pubitemid 37305656)
9. Sarnak MJ, Levy AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42:1050-1065 (Pubitemid 37413751)
10. Jamerson KA (2005) Preventing chronic kidney disease in special populations. Am J Hypertens 18:106S-111S (Pubitemid 40544827)
11. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PWF, Levy D (2005) Glycemic status and development of kidney disease: the Framingham heart study. Diabetes Care 28: 2436-2440 (Pubitemid 41384290)
12. Norris KC, Agodoa LY (2005) Unraveling the racial disparities associated with kidney disease. Kidney Int 68: 914-924 (Pubitemid 43246408)
13. Rule AD, Jacobsen SJ, Schwartz GL et al (2006) A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. Am J Hypertens 19:608-614 (Pubitemid 43775857)
14. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166:1884-1891 (Pubitemid 44455172)
15. Vupputuri S, Sandler DP (2003) Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 13:712-720 (Pubitemid 37346412)
16. Shultis WA, Weil EJ, Looker HC et al (2007) Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30:306-311 (Pubitemid 46198335)
17. Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ (2005) Periodontal disease is associated with renal insufficiency in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 45:650-657 (Pubitemid 40460753)
18. Monica AF, George WT (2009) A prediction model for chronic disease includes periodontal disease. J Periodontol 80:16-23
19. Caffesse RG, Nasjlete CE (1979) Enzymatic penetration through intact sulcular epithelium. J Periodontol 47:391-397
20. Saglie R, Newmann MG, Carranza FA Jr et al (1982) Bacterial invasion of gingiva in advanced periodontitis in humans. J Periodontol 53:217-222 (Pubitemid 12039267)
21. Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76:2106-2115 (Pubitemid 41748960)
22. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PME, Van Der Velden U (2000) Elevation of systemic markers related to cardiovascular disease in the peripheral blood of periodontitis patients. J Periodontol 71:1528-1534
23. Ebersole JL (1990) Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1:283-331 (Pubitemid 20361899)
24. Mantovani A, Garlanda C, Doni A, Bottazzi B (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28:1-13
25. Garlanda C, Bottazzi B, Bastone A, Mantovani A (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23:337-366 (Pubitemid 40563173)
26. Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81-88 (Pubitemid 24049801)
27. Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A et al (1992) Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 267:22190-22197
28. Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A (1994) Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84:3483-3493 (Pubitemid 24352913)
29. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E et al (2001) PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44:2841-2850 (Pubitemid 34016204)
30. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G et al (1997) Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins, C-reactive protein and serum amyloid P component. J Biol Chem 272: 32817-32823 (Pubitemid 28023616)
31. Pradeep AR, Kathariya R, Raghavendra NM, Sharma A (2010) Levels of pentraxin-3 in gingival crevicular fluid and Plasma in periodontal health and disease. J Periodontol 2010. doi:10.1902/jop.2010.100526. Ahead of print (Accepted 10 Oct 2010)
32. Loe H, Silness J (1963) Periodontal disease in pregnancy. I: prevalence and severity. Acta Odontol Scand 21:533
33. Okutani D (2006) The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses. Nihon Rinsho Meneki Gakkai Kaishi 29(3):107-113
34. Johnson NW, Griffiths GS, Wilton JM et al (1998) Detection of high-risk groups and individuals for periodontal disease. Evidence for the existence of higher groups and individuals and approaches to their detection. J Clin Periodontol 15:276-282
35. Stenvinkel P (2006) New insights on inflammation in chronic kidney disease-genetic and non-genetic factors. Nephrol Ther 2:111-119 (Pubitemid 44160677)
36. Cazzavillan S, Ratanarat R, Segala C et al (2007) Inflammation and subclinical infection in chronic kidney disease: a molecular approach. Blood Purif 25:69-76 (Pubitemid 46005755)
37. Pradeep AR, Shiva Manjunath RG, Kathariya R (2010) Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. JICD 1:133-138
38. Garcia RI, Henshaw MH, Krall EA (2001) Relationship between periodontal disease and systemic health. Periodontology 2000 25:21-36 (Pubitemid 33756032)
39. Inoue K, Sugiyama A, Reid PC et al (2007) Establishment of a high sensitivity plasma assay for human pentraxin 3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27:161-167 (Pubitemid 46360394)
40. Latini R, Maggioni AP, Peri G et al (2004) Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110:2349-2354 (Pubitemid 39407338)
41. Reading PC, Bozza S, Gilbertson B et al (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180:3391-3398
42. Tong M, Correro JJ, Qureshi AR et al (2007) Plasma pentraxin 3 in Patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2:889-897
43. Luchetti MM, Piccinini G, Mantovani A et al (2000) Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 119:196-202 (Pubitemid 30064610)
44. Cetin I, Cozzi V, Pasqualini F et al (2006) Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 194:1347-1353
45. Shingo K, Mitsuko O, Tomaya S et al (2008) Increased expression of long pentraxin in inflammatory bowel diseases. Dig Dis Sci 53:1910-1916
46. Albert TAM, Giuseppe P, Tatty ES et al (2005) Elevated plasma levels of the long pentraxin, pentraxin 3 in severe dengue virus infections. J Med Virol 76:547-552
47. Muller B, Peri G, Doni A et al (2001) Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29:1404-1407 (Pubitemid 32641804)
48. Peri G, Introna M, Corradi D, Lacuitti G, Signorini S, Avanzini F et al (2000) PTX3, a protototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102:636-641 (Pubitemid 30640663)
49. Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G et al (2002) Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells. A novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 22:782-787 (Pubitemid 34517789)
50. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino LS et al (2003) Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med 254:132-139 (Pubitemid 36900436)
51. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH (1998) Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244 (Pubitemid 28288040)
52. Yano A, Nakao K, Sarai A, Akagi S, Kihara T, Morimoto H, Nakamura A, Hiramatsu M, Nagake Y, Makino H (2005) Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis. Nephrology (Carlton) 10:576-582 (Pubitemid 41801837)
53. Boehme M, Kaehne F, Kuehne A, Bernhardt W, Schroder M, Pommer W et al (2007) Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant 22:2224-2229 (Pubitemid 47244700)
54. Tong M, Anderstam B, Sjöberg B, Alvestrand A (2006) Circulating levels of long pentraxin 3 (PTX3) are elevated in hemodialysis patients and increase acutely after a single HD session. J Am Soc Nephrol 17:735A
55. Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N et al (2007) Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod 76:102-117 (Pubitemid 46013453)
56. Suliman ME, Qureshi AR, Carrero JJ, Barany P, Yalmaz MI, Snaedal-Jonsdottir S et al. (2008) The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. Q J Med. doi:10.1093/qjmed/hcn019 (Pubitemid 351619248)